Plasma genotyping to predict treatment benefit in patients with NSCLC
Saturday, April 16, 2016 - 03:02
in Health & Medicine
The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies.